We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$7.18B
AUM Growth
+$277M
Cap. Flow
-$59.6M
Cap. Flow %
-0.83%
Top 10 Hldgs %
23.97%
Holding
248
New
10
Increased
74
Reduced
146
Closed
8

Top Buys

Rank Stock Value
1
IT icon
Gartner
IT
+$33M
2
AMZN icon
Amazon
AMZN
+$21.6M
3
DHR icon
Danaher
DHR
+$14.6M
4
APD icon
Air Products & Chemicals
APD
+$13.2M
5
CRM icon
Salesforce
CRM
+$12.9M

Top Sells

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$49.7M
2
ORCL icon
Oracle
ORCL
+$31.4M
3
NVDA icon
NVIDIA
NVDA
+$20.3M
4
AXP icon
American Express
AXP
+$18.6M
5
JPM icon
JPMorgan Chase
JPM
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 18.81%
2 Financials 17.13%
3 Healthcare 13.1%
4 Industrials 12.77%
5 Communication Services 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWK icon
126
Stanley Black & Decker
SWK
$15.7B
$5.39M 0.08%
72,485
+11,024
+18% +$808K
AL
127
DELISTED
Air Lease Corp
AL
$5.06M 0.07%
79,523
-221,039
-74% -$13.2M
OGN icon
128
Organon & Co
OGN
$3.57B
$4.74M 0.07%
443,876
+127,924
+40% +$1.26M
NYT icon
129
New York Times
NYT
$10.2B
$4.28M 0.06%
74,651
-15,571
-17% -$888K
MLKN icon
130
MillerKnoll
MLKN
$1.67B
$4.1M 0.06%
231,329
+7,043
+3% +$143K
STZ icon
131
Constellation Brands
STZ
$23.2B
$4.07M 0.06%
30,259
-67,180
-69% -$10.7M
COST icon
132
Costco
COST
$420B
$4.02M 0.06%
4,340
-146
-3% -$140K
AMGN icon
133
Amgen
AMGN
$222B
$3.8M 0.05%
13,473
+90
+0.7% +$26.1K
NKE icon
134
Nike
NKE
$61.9B
$2.91M 0.04%
41,765
+38,426
+1,151% +$2.86M
RBLX icon
135
Roblox
RBLX
$27B
$2.86M 0.04%
20,679
-9,283
-31% -$1.15M
WMT icon
136
Walmart Inc
WMT
$890B
$2.7M 0.04%
26,163
+3,749
+17% +$373K
PG icon
137
Procter & Gamble
PG
$339B
$2.6M 0.04%
16,936
-1,660
-9% -$259K
ABBV icon
138
AbbVie
ABBV
$435B
$2.31M 0.03%
9,986
-349
-3% -$71.1K
LLY icon
139
Eli Lilly
LLY
$1.06T
$2.25M 0.03%
2,946
-39
-1% -$29K
T icon
140
AT&T
T
$163B
$2.04M 0.03%
72,213
-19,694
-21% -$559K
ABT icon
141
Abbott
ABT
$187B
$2M 0.03%
14,902
-441
-3% -$57.9K
FDX icon
142
FedEx
FDX
$75.4B
$1.83M 0.03%
7,779
-199
-2% -$45.9K
BABA icon
143
Alibaba
BABA
$308B
$1.67M 0.02%
9,372
-5,373
-36% -$704K
CAT icon
144
Caterpillar
CAT
$387B
$1.56M 0.02%
3,275
-435
-12% -$186K
LAMR icon
145
Lamar Advertising Co
LAMR
$16.3B
$1.45M 0.02%
11,883
-150
-1% -$18.6K
CL icon
146
Colgate-Palmolive
CL
$74.4B
$1.44M 0.02%
17,954
-1,020
-5% -$87K
MRSH
147
Marsh
MRSH
$91.5B
$1.28M 0.02%
6,360
-417
-6% -$85.8K
ADP icon
148
Automatic Data Processing
ADP
$108B
$1.2M 0.02%
4,103
-77
-2% -$23.2K
ADBE icon
149
Adobe
ADBE
$105B
$1.2M 0.02%
3,404
+158
+5% +$56.7K
AVGO icon
150
Broadcom
AVGO
$2.04T
$1.12M 0.02%
3,389
-86
-2% -$26.4K

Similar funds

Douglas Lane & Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Douglas Lane & Associates held 248 positions worth $7.18B, up 4% from $6.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Douglas Lane & Associates's Q3 2025 filing shows 10 new, 74 increased, 146 reduced and 8 closed positions. Its largest new stake was Synopsys: 840 shares worth $414K. The largest sale was SLB Ltd, an estimated $49.7M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Douglas Lane & Associates's largest Q3 2025 buy was Synopsys: 840 shares worth $414K.
  • Douglas Lane & Associates added most to Gartner in Q3 2025, an estimated $33M increase.
  • Douglas Lane & Associates's biggest Q3 2025 reduction was Oracle, cutting an estimated $31.4M.
  • Douglas Lane & Associates fully exited SLB Ltd in Q3 2025, selling an estimated $49.7M.
  • Douglas Lane & Associates's ten largest holdings make up 24% of its $7.18B portfolio in Q3 2025.
  • Douglas Lane & Associates opened 10 new positions and closed 8 in Q3 2025.
  • Douglas Lane & Associates's portfolio value rose 4% quarter-over-quarter to $7.18B.

Based on Douglas Lane & Associates's 13F filing for Q3 2025, filed 10 Oct 2025.